Holmes Defends Theranos' 'Aggressive' IP Protection At Trial
Ex-Theranos CEO Elizabeth Holmes' cross-examination in her criminal fraud trial wrapped Tuesday, with Holmes conceding that she didn't tell investors Theranos was performing blood tests on modified third-party devices but defending...To view the full article, register now.
Already a subscriber? Click here to view full article